In ovarian cancer cells, COL11A1 modulates TGF-β3 via the NF-κB/IGFBP2 axis, thereby activating cancer-associated fibroblasts and influencing tumor development and migration (Wu et al., 2021). The gene discussed is IGFBP2; the disease is neoplasm.